The U.S. Food and Drug Administration approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD) in adult patients who have initiated treatment with a transmucosal (absorbed through mucus membrane) buprenorphine-containing product. It is indicated for patients that have been on a stable dose of buprenorphine treatment for a minimum of seven days.

The National Institutes of Health and partners have launched a large clinical trial to assess whether an experimental HIV vaccine regimen is safe and able to prevent HIV infection. The new Phase 2b proof-of-concept study, called Imbokodo, aims to enroll 2,600 HIV-negative women in sub-Saharan Africa. Of 1.8 million new HIV infections worldwide in 2016, 43 percent occurred in eastern and southern Africa, with women and girls disproportionately affected.

Hip impingement can happen for a number of reasons. If left untreated, the pain and other symptoms it causes may get worse as damage to the hip joint increases. Treatment for hip impingement depends largely on a person's individual circumstances. Generally though, treatment options range from managing symptoms with medication and physical therapy in milder cases to surgery in more severe cases.

Mayo Clinic researchers have shown a link between which type of oral anticoagulant (blood-thinning medication) a patient takes to prevent a stroke and increased risks of kidney function decline or failure.

Results from studies featured in the November issue of the journal Circulation: Cardiovascular Quality and Outcomes focus on the disparities in cardiovascular care found globally, emphasizing the importance of the American Heart Association's leadership as the world's leading voluntary health organization devoted to fighting cardiovascular disease.

Neurologist Thomas Brott, M.D., the Eugene and Marcia Applebaum Professor of Neurosciences on Mayo Clinic's Florida campus, has been selected as the recipient of the 2017 Research Achievement Award from the American Heart Association. He received the honor on Sunday, November 12, during the American Heart Association's Scientific Sessions in Anaheim, California. The recognition rewards distinguished lifetime scientific achievement in the field of cardiovascular research.